文献速递淋巴瘤

淋巴细胞/单核细胞比值在血管免疫母细胞性T细胞淋巴瘤中的预后价值

[Prognostic value of lymphocyte-to-monocyte ratio in angioimmunoblastic T cell lymphoma].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2018-01-01

回顾性分析64例初诊血管免疫母细胞性T细胞淋巴瘤(AITL)患者,ROC曲线确定淋巴细胞/单核细胞比值(LMR)临界值为3.07。低LMR组无进展生存(PFS)和总生存(OS)均较差,多因素分析显示低LMR是独立预后不良因素。亚组分析中,仅非特指型预后指数(PIT)评分2~4分患者低LMR与更短PFS和OS相关。

要点

  • LMR临界值为3.07,低LMR组PFS 9个月 vs 高LMR组13个月(P=0.044)。
  • 低LMR组OS 16个月 vs 高LMR组未达到(P=0.014)。
  • PIT评分2~4分患者中低LMR者PFS和OS更短(P=0.013、P=0.031)。

核心结论

  • 可根据PIT评分及LMR状态初步评估AITL患者的疾病风险。
  • 低LMR提示AITL患者具有更差的预后。

研究设计与样本

  • 回顾性分析2009年6月至2017年7月南京医科大学第一附属医院收治的64例初诊AITL患者资料。
  • 采用ROC曲线计算LMR临界值并分组,Kaplan-Meier法和Cox回归分析预后因素。

主要发现

  • 64例患者中男39例、女25例,中位年龄63(29~89)岁;LMR临界值为3.07。
  • 中位随访33(5~103)个月,低LMR组PFS 9个月 vs 高LMR组13个月(P=0.044),OS 16个月 vs 高LMR组未达到(P=0.014)。
  • 多因素分析显示低LMR是影响PFS(HR=0.48,95%CI 0.26~0.92,P=0.027)和OS(HR=0.38,95%CI 0.18~0.82,P=0.013)的独立预后不良因素。
  • PIT评分2~4分患者中,低LMR者PFS和OS更短(P=0.013、P=0.031);PIT评分0~1分患者中低LMR对PFS和OS影响无统计学意义(P=0.949、P=0.238)。

关键数值与推荐

  • LMR临界值为3.07。
  • 低LMR组PFS 9个月 vs 高LMR组13个月(P=0.044)。
  • 低LMR组OS 16个月 vs 高LMR组未达到(P=0.014)。
  • 低LMR影响PFS的HR=0.48(95%CI 0.26~0.92,P=0.027),影响OS的HR=0.38(95%CI 0.18~0.82,P=0.013)。

临床怎么用

  • 原文结论认为可根据PIT评分及LMR状态初步评估患者的疾病风险,低LMR提示更差预后。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To evaluate the prognostic value of lymphocyte-to-monocyte ratio (LMR) in angioimmunoblastic T cell lymphoma (AITL). Methods: Data of 64 patients diagnosed as AITL at the First Affiliated Hospital of Nanjing Medical University between June 2009 and July 2017, were analyzed retrospectively. Receiver Operator Characteristic (ROC) curve was used to calculate the cutoff value of LMR to divide this cohort of patients into high and low LMR groups. Characteristics between groups were compared by Pearson Chi-square or Fisher exact tests. Kaplan-Meier method and Cox regression were performed to probe prognostic factors associated with progression-free survival (PFS) and overall survival (OS). Results: A total of 64 cases [39 cases male and 25 ones female with the median age of 63 (29-89) years old] were enrolled. The cutoff value of LMR was 3.07. Patients with low LMR showed inferior PFS (9 months vs 13 months, P=0.044) and OS (16 months vs not reached, P=0.014), respectively than those without low LMR during a median follow-up of 33 months (5 to 103 months). Multivariate analysis showed that low LMR was an independent prognostic factor associated with poor outcomes (HR=0.48, 95% CI 0.26-0.92 for PFS, P=0.027; HR=0.38, 95% CI 0.18-0.82 for OS, P=0.013, respectively). Subgroup analysis showed that patients with low LMR and under the situation of high score of Prognostic Index for peripheral T-cell lymphoma, Unspecified (PIT) (2-4) had shorter PFS and OS (P=0.013 and P=0.031, respectively). But in low score of PIT (0-1) group, low LMR seemed to play almost no effects on PFS and OS (P=0.949 and P=0.238, respectively). Conclusions: The disease risk status of patients could be initially assessed according to PIT score and LMR level. Low LMR was demonstrated to be able to predict poor outcome in AITL. 目的: 探究淋巴细胞/单核细胞比值(LMR)在血管免疫母细胞性T细胞淋巴瘤(AITL)患者中的预后价值。 方法: 回顾性分析2009年6月至2017年7月南京医科大学第一附属医院收治的64例初诊AITL患者资料。采用ROC曲线计算LMR临界值,并以此将患者分为高LMR和低LMR组,采用Pearson卡方检验及Fisher精确概率法进行组间比较。采用Kaplan-Meier法和Cox回归分析影响无进展生存(PFS)和总生存(OS)的预后因素。 结果: 64例患者中,男39例,女25例,中位年龄63(29~89)岁。LMR临界值为3.07。中位随访33(5~103)个月,低LMR与高LMR组比较,患者的PFS时间(9对13个月,P=0.044)和OS时间(16个月对未达到,P=0.014)差异均有统计学意义。多因素分析显示低LMR是影响患者PFS(HR=0.48, 95% CI 0.26~0.92,P=0.027)和OS(HR=0.38,95% CI 0.18~0.82,P=0.013)的独立预后不良因素。亚组分析结果显示,在中高危至高危[非特指型预后指数(PIT)评分2~4分]患者中,低LMR者有更短的PFS和OS时间(P值分别为0.013、0.031),而在低危至中低危(PIT评分0~1分)患者中其差异均无统计学意义(P值分别为0.949、0.238)。 结论: 可根据PIT评分及LMR的状态初步评估患者的疾病风险。低LMR提示患者具有更差的预后。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Niu JY, Zhu HY, Wang L, et al. [Prognostic value of lymphocyte-to-monocyte ratio in angioimmunoblastic T cell lymphoma]. Zhonghua Xue Ye Xue Za Zhi. 2018. PMID: 29779318. doi:10.3760/cma.j.issn.0253-2727.2018.04.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。